Completed
Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
NCT00671970
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
- Locations
-
- Duke University Health System Durham, North Carolina, United States